您的位置: 首页 > 农业专利 > 详情页

pharmaceutical administration form comprising 5-chloro-n - ({(5s) -2-oxo-3 - [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidine-5-yl} - methyl - 2 - thiophenecarboxamide
专利权人:
BAYER PHARMA AKTIENGESELLSCHAFT
发明人:
HEIKE NEUMANN,KLAUS BENKE,WOLFGANG MÜCK
申请号:
BR112015000043
公开号:
BR112015000043A2
申请日:
2013.06.28
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to solid orally administrable pharmaceutical administration forms comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide (rivaroxaban, active compound (I)), wherein a partial amount of the active compound (I) is released rapidly and a partial amount is released in a controlled manner (modified, retarded, delayed), and to processes for their preparation, their use as medicaments and their use for the prophylaxis, secondary prophylaxis or treatment of disorders.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充